BROOKSNSEBrooks Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Sat, 30 May · 12:39 IST

Newspaper Publication dated 30th May 2026 of Audited Financial Results for the quarter and year ended 31st March 2026.

BROOKS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+3.2%1-day move
₹65.29
prior close
₹68.55
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.8-1.5-0.0+0.0+3.2-0.4+0.9+0.8+2.6+4.5+7.2+10.7
Up moveDown movePending
AI summary

Brooks Laboratories Limited published its audited standalone and consolidated financial results for Q4 FY2026 and full year FY2026 in Financial Express and Jansatta newspapers on 30th May 2026. The results were published pursuant to SEBI Regulation 47 of the Listing Obligations and Disclosures Requirements Regulations, 2015. Key figures from the consolidated results show net profit of Rs. 4.529 crore for the full year, with Q4 standalone net profit of Rs. 3.543 crore. The filing includes comparisons with previous year figures and was signed by Company Secretary Krutika Rane. The company is listed on BSE (Scrip Code: 533543) and NSE (Symbol: BROOKS) with its registered office in Baddi, Himachal Pradesh.

Likely market impact

This is a routine financial results publication as required by SEBI regulations. The audited results provide shareholders with official year-end performance data. No immediate market-moving information is contained in this publication filing as the results were already announced to the exchanges.